FROM OUR BLOG

HealthSpan’s $5.7B Surgery Partners Bid; Fed Decision Looms

HealthSpan makes a $5.7B bid for Surgery Partners, while markets brace for the Fed's rate call and megacap tech earnings this week.

October 28, 2026

Healthcare Practice & Business Deals

One major outpatient acquisition dominated healthcare deal news this week, while the broader market awaited the Federal Reserve’s next move.

HealthSpan Bids $5.7 Billion for Surgery Partners. HealthSpan, the investment arm of Bon Secours, has made a $5.7 billion offer to take Surgery Partners private. Surgery Partners operates outpatient surgical facilities across 30 states. HealthSpan’s bid would absorb that entire footprint into the Bon Secours network. The proposal aims to move Surgery Partners off public markets entirely. No closing date has been announced.

No Additional Qualifying Small/Medium Practice Deals This Week. The remaining healthcare candidates this week cover large for-profit hospital earnings, biopharma acquisitions, policy developments, and health-tech funding. None represent the named small-to-medium independent or group practice transactions this section typically features. The Surgery Partners bid is the sole specific acquisition deal in this edition’s source material.

Global Markets & Macro

Markets this week are pulled in several directions at once — tech earnings, a Fed decision, energy disruptions, and a high-stakes UK budget all competing for attention.

Fed Rate Decision Takes Center Stage. The Federal Reserve is widely expected to leave interest rates unchanged at its Wednesday meeting. However, commentary from economists is growing sharper. Claudia Sahm, chief economist at New Century Advisors, argued publicly that there is a strong economic case for raising rates by a quarter point today. Treasury yields edged higher ahead of the decision. The dollar held broadly steady. Markets are watching closely for any shift in the Fed’s forward guidance.

Megacap Tech Earnings Drive Stock Momentum. US stock futures struggled for traction ahead of results from Microsoft and Alphabet, both due after the close Wednesday. Meanwhile, traders rotated back into tech stocks on renewed confidence that AI spending will continue to pay off. SK Hynix reported a stronger-than-expected sevenfold profit surge and unveiled plans to return roughly $45 billion more to shareholders. The results pointed to resilient AI infrastructure demand driving chip sales higher.

UK Chancellor Healey Delivers Debut Budget. UK Chancellor John Healey faced competing pressures as he delivered his first budget statement. He moved to tackle cost-of-living concerns, including energy costs, while trying to avoid alarming bond markets. Healey also confirmed he would reverse a planned cut to the cash ISA allowance, keeping the tax-free limit at £20,000 per year. Bond investors watched closely. Pimco economist Peder Beck-Friis said a UK fiscal deficit of around 3.5% for 2027 would be welcome news for the gilt market.

GE Vernova Agrees to Buy Trench Group for $9 Billion. GE Vernova agreed to acquire Trench Group for $9 billion. The deal targets high-voltage grid equipment — a segment under intense demand pressure as electrification and AI data center buildout accelerate globally. The acquisition signals that energy infrastructure investment continues to surge, regardless of broader macro uncertainty.

Saudi Oil Exports Hold Near Wartime Highs Despite Attacks. Saudi Arabia’s oil exports are holding near wartime highs this month. That is despite a wave of Houthi attacks on Saudi energy infrastructure and reported Iranian strikes on tankers in the Strait of Hormuz. Preliminary ship-tracking data confirm the volumes. The resilience of Saudi supply is keeping global oil markets from a sharper spike, even as geopolitical risk in the region remains elevated.

Jio’s IPO Topples Tata as India’s Most Valuable Conglomerate. Jio Platforms made a blockbuster stock market debut that propelled parent Reliance Industries past Tata Group in total market value. The listing marks a significant shift in India’s corporate landscape. It also reflects strong global investor appetite for emerging-market digital plays, even as developed-market equities remain uncertain ahead of the Fed.

What to Watch

The Federal Reserve’s Wednesday rate decision will set the tone for markets heading into November. Any surprise in language around future hikes — with voices like Claudia Sahm already calling for action — could jolt bond yields and rattle rate-sensitive sectors, including healthcare deal financing. Microsoft and Alphabet results will test whether AI optimism can sustain the tech rally that lifted chip stocks this week. In healthcare, the HealthSpan bid for Surgery Partners is worth tracking closely: a $5.7 billion move to privatize a 30-state outpatient network signals that large-scale ambulatory consolidation is far from finished. Practice owners and advisors should note how deal financing responds if the Fed signals a more hawkish posture than markets currently expect.


Editorial note, image use & corrections. This report is compiled and summarized from publicly available news sources; figures and details should be independently verified. Accompanying images are used under Creative Commons or public-domain licenses (sourced via Openverse) and credited where required. If you believe any content — written or image — has been used in error, is inaccurate, or infringes your rights, or you wish to request a correction or removal, please contact us at info@tenetma.com and we will address it promptly.

What do these market moves mean for your practice value?

Get a confidential read on what your practice is worth in today's market.

Request a confidential review

About Tenet Mergers & Acquisitions

Tenet Mergers & Acquisitions is a sell-side advisory firm for healthcare practice owners exploring a sale, partnership or transition.

Meet the team

THINKING ABOUT SELLING YOUR MEDICAL PRACTICE?

Get a confidential practice valuation.

If you’re considering selling your practice — or exploring your options — a confidential valuation is a helpful first step. Understanding market conditions and potential value provides clarity and supports better decisions around timing and strategy.

START THE CONVERSATION

If you’re considering a sale, exploring acquisitions or planning ahead,
we’re here to help.

Schedule a confidential consultation to learn how our services can support your goals.